These effects occurred at well-tolerated doses of CYC065 (Supplemental Figure 8D), suggesting a clear therapeutic index for CYC065 in the most highly aggressive MYCN-deregulated forms of NB. The gene discussed is MYCN; the disease is neuroblastoma.